Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes

Author:

Li Shiliang1,Xu Hongling1,Cui Shichao2,Wu Fangshu1,Zhang Youli1,Su Mingbo2,Gong Yinghui1,Qiu Shaobing1,Jiao Qian1,Qin Chun1,Shan Jiwei1,Zhang Ming1,Wang Jiawei1,Yin Qiao1,Xu Minghao1,Liu Xiaofeng1,Wang Rui1,Zhu Lili1,Li Jia2,Xu Yufang1,Jiang Hualiang2,Zhao Zhenjiang1,Li Jingya2,Li Honglin1

Affiliation:

1. State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China

2. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Shanghai 201203, China

Funder

Ministry of Education of the People's Republic of China

Shanghai Municipal Education Commission

National Natural Science Foundation of China

Ministry of Science and Technology of the People\'s Republic of China

Shanghai Municipal Science and Technology Commission

Fok Ying Tung Education Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3